Literature DB >> 28526213

Epidemiology of neurocysticercosis and epilepsy, is everything described?

Jose F Tellez-Zenteno1, Lizbeth Hernandez-Ronquillo2.   

Abstract

In recent years clinical and epidemiological research on cysticercosis has gained significant interest in some countries, especially in Latin American countries and some countries in Asia and Africa. For many years it has been proposed that the higher prevalence of epilepsy seen in some regions such as Latin-America could be explained by parasitic infections, particularly neurocysticercosis (NCC). In this review we discussed selected epidemiological topics of the association of NCC and epilepsy, such as global distribution around the world, identification of NCC in developed countries, drug resistant epilepsy and NCC. Finally this review presents a critical review of biases of the published literature in NCC. This article is part of a Special Issue entitled "Neurocysticercosis and Epilepsy".
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epidemiology; Epilepsy; Neurocysticercosis; Taeniasis

Mesh:

Year:  2017        PMID: 28526213     DOI: 10.1016/j.yebeh.2017.01.030

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  7 in total

1.  In vivo treatment of experimental neurocysticercosis with praziquantel nanosuspensions-a metabolic approach.

Authors:  Luciana Damacena Silva; Nayana Ferreira Lima; Eva Carolina Arrua; Claudio Javier Salomon; Marina Clare Vinaud
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

2.  Exploring the complex associations over time among albendazole treatment, cyst evolution, and seizure outcomes in neurocysticercosis.

Authors:  Arturo Carpio; Mindy Chang; Hongbin Zhang; Matthew L Romo; Alex Jaramillo; W Allen Hauser; Elizabeth A Kelvin
Journal:  Epilepsia       Date:  2019-07-29       Impact factor: 5.864

3.  The primary prevention of epilepsy: A report of the Prevention Task Force of the International League Against Epilepsy.

Authors:  David J Thurman; Charles E Begley; Arturo Carpio; Sandra Helmers; Dale C Hesdorffer; Jie Mu; Kamadore Touré; Karen L Parko; Charles R Newton
Journal:  Epilepsia       Date:  2018-04-10       Impact factor: 5.864

4.  Aetiological Features of Elderly Patients with Newly Diagnosed Symptomatic Epilepsy in Western China.

Authors:  Yi Guo; Liang Yu; Baoming He; Suping Li; Qiong Zhu; Hongbin Sun
Journal:  Biomed Res Int       Date:  2018-04-24       Impact factor: 3.411

5.  Evaluating the Association of Calcified Neurocysticercosis and Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis in a Large Cohort of Patients With Epilepsy.

Authors:  Thaís Leite Secchi; Rosane Brondani; José Augusto Bragatti; Jorge Wladimir Junqueira Bizzi; Marino Muxfeldt Bianchin
Journal:  Front Neurol       Date:  2022-01-27       Impact factor: 4.003

6.  The Association between Neurocysticercosis and Epilepsy.

Authors:  Arturo Carpio
Journal:  Am J Trop Med Hyg       Date:  2020-09       Impact factor: 2.345

Review 7.  Unique Characteristics of Epilepsy Development in Neurocysticercosis.

Authors:  Jesica A Herrick; Javier A Bustos; Philip Clapham; Hector H Garcia; Jeffrey A Loeb
Journal:  Am J Trop Med Hyg       Date:  2020-05-14       Impact factor: 2.345

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.